Post by fantomEUproject

The fantomEUproject podcast series presents a new conversation with Aiindrila Dhara (Masaryk University), focusing on one of the key challenges in modern oncology: treatment resistance in childhood lymphoma. Aiindrila discusses ALK-positive Anaplastic Large Cell Lymphoma (ALCL) and why a small subset of patients relapses or does not respond to otherwise highly effective therapies, despite cure rates above 90%. 🧬 Her research explores tumour heterogeneity and how diverse cancer cell populations within the same tumour contribute to different treatment outcomes. 🔬 Using DNA barcoding, individual cancer cell clones can be tracked over time to identify which cells survive therapeutic pressure. ⚡ This approach helps uncover how resistant populations emerge and may inform future combination therapies for patients with limited treatment options. 🎧 Listen here: https://lnkd.in/dRiCMUxM #MasarykUni #Science_MEDMUNI #TU_Muenchen #UKEHamburg #unimib #unito #Pathologie_MUW #UniPadova #CamPathology #Biolution #NakedScientists